Fidaxomicin Inhibits Spore Production in Clostridium difficile

Fidaxomicin (FDX) is a novel antimicrobial agent with narrow-spectrum and potent bactericidal activity against Clostridium difficile. In recent clinical trials, FDX was superior to vancomycin in preventing recurrences of C. difficile infection. A possible mechanism of reducing recurrence may be thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Babakhani, Farah, Bouillaut, Laurent, Gomez, Abraham, Sears, Pamela, Nguyen, Ly, Sonenshein, Abraham L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388029/
https://www.ncbi.nlm.nih.gov/pubmed/22752866
http://dx.doi.org/10.1093/cid/cis453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388029/
https://www.ncbi.nlm.nih.gov/pubmed/22752866
http://dx.doi.org/10.1093/cid/cis453

Ejemplares similares